Antiaging Quantum Living Inc. (AAQL) EBITDA Margin (2019 - 2025)

Antiaging Quantum Living (AAQL) has 7 years of EBITDA Margin data on file, last reported at 73.18% in Q4 2025.

• Quarterly EBITDA Margin fell 595.0% year-over-year to 73.18% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 48.79% (up 10050.0% YoY) and the FY2025 annual result came in at 87.65%, up 538459.0% from the prior year.
• EBITDA Margin retreated to 73.18% in Q4 2025 per AAQL's latest filing, from 16.5% in the prior quarter.
• The five-year high for EBITDA Margin was 16.5% in Q3 2025, with the low at 2477.25% in Q2 2023.
• Average EBITDA Margin over 5 years is 543.42%, with a median of 169.3% recorded in 2022.
• Year-over-year, EBITDA Margin soared 481325 bps in 2021 and plunged 159788 bps in 2023.
• Antiaging Quantum Living's EBITDA Margin stood at 1379.29% in 2021, then surged by 88 bps to 169.3% in 2022, then tumbled by 817 bps to 1553.09% in 2023, then jumped by 96 bps to 67.23% in 2024, then retreated by 9 bps to 73.18% in 2025.
• Business Quant data shows AAQL's EBITDA Margin at 73.18% in Q4 2025, 16.5% in Q3 2025, and 48.49% in Q2 2025.